| Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism H Zhao, L Yang, J Baddour, A Achreja, V Bernard, T Moss, JC Marini, ... elife 5, e10250, 2016 | 872 | 2016 |
| Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells CJ Denman, VV Senyukov, SS Somanchi, PV Phatarpekar, LM Kopp, ... PloS one 7 (1), e30264, 2012 | 710 | 2012 |
| A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR H Torikai, A Reik, PQ Liu, Y Zhou, L Zhang, S Maiti, H Huls, JC Miller, ... Blood, The Journal of the American Society of Hematology 119 (24), 5697-5705, 2012 | 685 | 2012 |
| CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells CM Kowolik, MS Topp, S Gonzalez, T Pfeiffer, S Olivares, N Gonzalez, ... Cancer research 66 (22), 10995-11004, 2006 | 683 | 2006 |
| Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans MC Jensen, L Popplewell, LJ Cooper, D DiGiusto, M Kalos, JR Ostberg, ... Biology of blood and marrow transplantation 16 (9), 1245-1256, 2010 | 669 | 2010 |
| Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells P Kebriaei, H Singh, MH Huls, MJ Figliola, R Bassett, S Olivares, B Jena, ... The Journal of clinical investigation 126 (9), 3363-3376, 2016 | 559 | 2016 |
| Cord-blood engraftment with ex vivo mesenchymal-cell coculture M De Lima, I McNiece, SN Robinson, M Munsell, M Eapen, M Horowitz, ... New England Journal of Medicine 367 (24), 2305-2315, 2012 | 546 | 2012 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 531* | 2021 |
| Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor B Jena, G Dotti, LJN Cooper Blood, The Journal of the American Society of Hematology 116 (7), 1035-1044, 2010 | 508 | 2010 |
| Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype K Gabrusiewicz, B Rodriguez, J Wei, Y Hashimoto, LM Healy, SN Maiti, ... JCI insight 1 (2), 2016 | 450 | 2016 |
| Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells KS Kahlon, C Brown, LJN Cooper, A Raubitschek, SJ Forman, ... Cancer research 64 (24), 9160-9166, 2004 | 445 | 2004 |
| Tuning sensitivity of CAR to EGFR density limits recognition of normal tissue while maintaining potent antitumor activity HG Caruso, LV Hurton, A Najjar, D Rushworth, S Ang, S Olivares, T Mi, ... Cancer research 75 (17), 3505-3518, 2015 | 440 | 2015 |
| Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells LV Hurton, H Singh, AM Najjar, KC Switzer, T Mi, S Maiti, S Olivares, ... Proceedings of the National Academy of Sciences 113 (48), E7788-E7797, 2016 | 433 | 2016 |
| Safety and efficacy of intratumoral injections of chimeric antigen receptor (CAR) T cells in metastatic breast cancer J Tchou, Y Zhao, BL Levine, PJ Zhang, MM Davis, JJ Melenhorst, ... Cancer immunology research 5 (12), 1152-1161, 2017 | 421 | 2017 |
| Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy DA Knorr, Z Ni, D Hermanson, MK Hexum, L Bendzick, LJN Cooper, ... Stem cells translational medicine 2 (4), 274-283, 2013 | 402 | 2013 |
| Toward eliminating HLA class I expression to generate universal cells from allogeneic donors H Torikai, A Reik, F Soldner, EH Warren, C Yuen, Y Zhou, DL Crossland, ... Blood, The Journal of the American Society of Hematology 122 (8), 1341-1349, 2013 | 371 | 2013 |
| T-cell clones can be rendered specific for CD19: Toward the selective augmentation of the graft-versus-B–lineage leukemia effect LJN Cooper, MS Topp, LM Serrano, S Gonzalez, WC Chang, A Naranjo, ... Blood, The Journal of the American Society of Hematology 101 (4), 1637-1644, 2003 | 364 | 2003 |
| Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing KV Komanduri, LS St. John, M De Lima, J McMannis, S Rosinski, ... Blood, The Journal of the American Society of Hematology 110 (13), 4543-4551, 2007 | 357 | 2007 |
| Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells MJ Frigault, J Lee, MC Basil, C Carpenito, S Motohashi, J Scholler, ... Cancer immunology research 3 (4), 356-367, 2015 | 344 | 2015 |
| Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL X Wang, LL Popplewell, JR Wagner, A Naranjo, MS Blanchard, MR Mott, ... Blood, The Journal of the American Society of Hematology 127 (24), 2980-2990, 2016 | 342 | 2016 |
George McNamaraUniversity of MiamiVerified email at med.miami.edu
